Primary Site >> Liver Cancer
Gene >> FBXW7
| 1. | |||||||||||
| Journal: | Hepatology. 2011 Jan;53(1):148-59. | ||||||||||
| Title: | Novel mechanism by which histone deacetylase inhibitors facilitate topoisomerase IIalpha degradation in hepatocellular carcinoma cells. | ||||||||||
| Author: | Chen, Mei-Chuan|Chen, Chun-Han|Chuang, Hsiao-Ching|Kulp, Samuel K|Teng, Che-Ming|Chen, Ching-Shih | ||||||||||
| PMID: | 21254166 | ||||||||||
| 2. | |||||||||||
| Journal: | Hepatology. 2012 Sep;56(3):1015-24. | ||||||||||
| Title: | Hepatitis B virus X protein stabilizes amplified in breast cancer 1 protein and cooperates with it to promote human hepatocellular carcinoma cell invasiveness. | ||||||||||
| Author: | Liu, Yonghong|Tong, Zhangwei|Li, Ting|Chen, Qiang|Zhuo, Luting|Li, Wengang|Wu, Ray-Chang|Yu, Chundong | ||||||||||
| PMID: | 22473901 | ||||||||||
| 3. | |||||||||||
| Journal: | Hepatol Res. 2012 Sep;42(9):904-10. | ||||||||||
| Title: | Evaluation of Fbxw7 expression and its correlation with the expression of c-Myc, cyclin E and p53 in human hepatocellular carcinoma. | ||||||||||
| Author: | Tu, Kangsheng|Zheng, Xin|Zan, Xianfeng|Han, Shaoshan|Yao, Yingmin|Liu, Qingguang | ||||||||||
| PMID: | 22548670 | ||||||||||
| 4. | |||||||||||
| Journal: | Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2012 Dec;28(12):1303-6. | ||||||||||
| Title: | [Expression of Fbxw7 and its correlation with cell proliferation in human hepatocellular carcinoma]. | ||||||||||
| Author: | Zhou, Zhen-yu|Tu, Kang-sheng|Zhang, Jing|Zheng, Xin|Gao, Jie|Yao, Ying-min|Liu, Qing-guang | ||||||||||
| PMID: | 23232523 | ||||||||||
| 5. | |||||||||||
| Journal: | PLoS One. 2013 Jul 1;8(7):e68574. | ||||||||||
| Title: | Recombinant human adenovirus-p53 injection induced apoptosis in hepatocellular carcinoma cell lines mediated by p53-Fbxw7 pathway, which controls c-Myc and cyclin E. | ||||||||||
| Author: | Tu, Kangsheng|Zheng, Xin|Zhou, Zhenyu|Li, Chao|Zhang, Jing|Gao, Jie|Yao, Yingmin|Liu, Qingguang | ||||||||||
| PMID: | 23840897 | ||||||||||
| 6. | |||||||||||
| Journal: | PLoS One. 2014 Feb 19;9(2):e89388. | ||||||||||
| Title: | FBXW7 mutations in patients with advanced cancers: clinical and molecular characteristics and outcomes with mTOR inhibitors. | ||||||||||
| Author: | Jardim, Denis L|Wheler, Jennifer J|Hess, Kenneth|Tsimberidou, Apostolia M|Zinner, Ralph|Janku, Filip|Subbiah, Vivek|Naing, Aung|Piha-Paul, Sarina A|Westin, Shannon N|Roy-Chowdhuri, Sinchita|Meric-Bernstam, Funda|Hong, David S | ||||||||||
| PMID: | 24586741 | ||||||||||
| 7. | |||||||||||
| Journal: | Hepatobiliary Pancreat Dis Int. 2014 Apr;13(2):184-91. | ||||||||||
| Title: | FBW7 increases chemosensitivity in hepatocellular carcinoma cells through suppression of epithelial-mesenchymal transition. | ||||||||||
| Author: | Yu, Jun|Zhang, Wu|Gao, Feng|Liu, Yuan-Xing|Chen, Zhi-Yun|Cheng, Long-Yu|Xie, Shang-Fen|Zheng, Shu-Sen | ||||||||||
| PMID: | 24686546 | ||||||||||
| 8. | |||||||||||
| Journal: | J Gastroenterol Hepatol. 2014 Oct;29(10):1822-9. | ||||||||||
| Title: | Role of Fbxw7 expression in hepatocellular carcinoma and adjacent non-tumor liver tissue. | ||||||||||
| Author: | Imura, Satoru|Tovuu, Lkhagva-Ochir|Utsunomiya, Tohru|Morine, Yuji|Ikemoto, Tetsuya|Arakawa, Yusuke|Kanamoto, Mami|Iwahashi, Shuichi|Saito, Yu|Takasu, Chie|Yamada, Shinichiro|Ishikawa, Daichi|Bando, Yoshimi|Shimada, Mitsuo | ||||||||||
| PMID: | 24731221 | ||||||||||
| 9. | |||||||||||
| Journal: | Mol Cancer. 2014 May 17;13:110. | ||||||||||
| Title: | Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma. | ||||||||||
| Author: | Tu, Kangsheng|Yang, Wei|Li, Chao|Zheng, Xin|Lu, Zhongtang|Guo, Cheng|Yao, Yingmin|Liu, Qingguang | ||||||||||
| PMID: | 24884509 | ||||||||||
| 10. | |||||||||||
| Journal: | Biochem Biophys Res Commun. 2014 Nov 7;454(1):71-7. | ||||||||||
| Title: | RBP-J-interacting and tubulin-associated protein induces apoptosis and cell cycle arrest in human hepatocellular carcinoma by activating the p53-Fbxw7 pathway. | ||||||||||
| Author: | Wang, Haihe|Yang, Zhanchun|Liu, Chunbo|Huang, Shishun|Wang, Hongzhi|Chen, Yingli|Chen, Guofu | ||||||||||
| PMID: | 25445601 | ||||||||||
| 11. | |||||||||||
| Journal: | Oncol Rep. 2015 Nov;34(5):2576-84. | ||||||||||
| Title: | MicroRNA-92a contributes to tumor growth of human hepatocellular carcinoma by targeting FBXW7. | ||||||||||
| Author: | Yang, Wei|Dou, Changwei|Wang, Yufeng|Jia, Yuli|Li, Chao|Zheng, Xin|Tu, Kangsheng | ||||||||||
| PMID: | 26323375 | ||||||||||
| 12. | |||||||||||
| Journal: | Rinsho Byori. 2015 Sep;63(9):1091-102. | ||||||||||
| Title: | [Alternative Splicing Detection as a Biomarker for Cancer Diagnosis: A Novel Progressive Mechanism of Acute Lymphoblastic Leukemia with Alternative Splicing as a Biomarker Candidate]. | ||||||||||
| Author: | Kitamura, Kouichi|Matsushita, Kazuyuki|Kobayashi, Souhei|Ishige, Takayuki|Semba, Toshihisa|Kimura, Asako|Kazami, Takahiro|Ohyama, Masayuki|Itoga, Sakae|Beppu, Minako|Nishimura, Motoi|Satoh, Mamoru|Nomura, Fumio | ||||||||||
| PMID: | 26731899 | ||||||||||
| 13. | |||||||||||
| Journal: | Cancer Cell Int. 2015 Nov 26;15:111. | ||||||||||
| Title: | STAT1 inhibits human hepatocellular carcinoma cell growth through induction of p53 and Fbxw7. | ||||||||||
| Author: | Chen, Jiayu|Wang, Haihe|Wang, Jing|Huang, Shishun|Zhang, Wei | ||||||||||
| PMID: | 26617467 | ||||||||||
| 14. | |||||||||||
| Journal: | Oncol Rep. 2015 Nov;34(5):2215-24. | ||||||||||
| Title: | Regulation mechanism of Fbxw7-related signaling pathways (Review). | ||||||||||
| Author: | Zhou, Zhenyu|He, Chuanchao|Wang, Jie | ||||||||||
| PMID: | 26324296 | ||||||||||
| 15. | |||||||||||
| Journal: | Int J Oncol. 2015 Jul;47(1):231-43. | ||||||||||
| Title: | Fbxw7 regulates hepatocellular carcinoma migration and invasion via Notch1 signaling pathway. | ||||||||||
| Author: | Wang, Xing|Zhang, Juan|Zhou, Liang|Sun, Wei|Zheng, Zhi-Gang|Lu, Peng|Gao, Yuan|Yang, Xi-Sheng|Zhang, Zhuo-Chao|Tao, Kai-Shan|Dou, Ke-Feng | ||||||||||
| PMID: | 25955618 | ||||||||||
| 16. | |||||||||||
| Journal: | Int J Mol Sci. 2015 Jan 22;16(2):2294-306. | ||||||||||
| Title: | FBXW7 acts as an independent prognostic marker and inhibits tumor growth in human osteosarcoma. | ||||||||||
| Author: | Li, Zhanchun|Xiao, Jie|Hu, Kongzu|Wang, Gang|Li, Maoqiang|Zhang, Jidong|Cheng, Guangqi | ||||||||||
| PMID: | 25622249 | ||||||||||
| 17. | |||||||||||
| Journal: | Tumour Biol. 2016 May;37(5):6045-51. | ||||||||||
| Title: | Wnt/beta-catenin signaling inhibits FBXW7 expression by upregulation of microRNA-770 in hepatocellular carcinoma. | ||||||||||
| Author: | Wu, Wen-Jie|Shi, Jia|Hu, Gang|Yu, Xin|Lu, Han|Yang, Ming-Liang|Liu, Bin|Wu, Zhi-Xiang | ||||||||||
| PMID: | 26602384 | ||||||||||
| 18. | |||||||||||
| Journal: | Cancer Res. 2016 Mar 1;76(5):1260-72. | ||||||||||
| Title: | Arginine Methylation of SREBP1a via PRMT5 Promotes De Novo Lipogenesis and Tumor Growth. | ||||||||||
| Author: | Liu, Liu|Zhao, Xiaoping|Zhao, Li|Li, Jiajin|Yang, Hao|Zhu, Zongping|Liu, Jianjun|Huang, Gang | ||||||||||
| PMID: | 26759235 | ||||||||||
| 19. | |||||||||||
| Journal: | J Exp Clin Cancer Res. 2016 Jun 16;35(1):93. | ||||||||||
| Title: | MicroRNA-155-3p promotes hepatocellular carcinoma formation by suppressing FBXW7 expression. | ||||||||||
| Author: | Tang, Bo|Lei, Biao|Qi, Guangying|Liang, Xingsi|Tang, Fang|Yuan, Shengguang|Wang, Zhenran|Yu, Shuiping|He, Songqing | ||||||||||
| PMID: | 27306418 | ||||||||||
| 20. | |||||||||||
| Journal: | Am J Transl Res. 2016 Jun 15;8(6):2512-24. eCollection 2016. | ||||||||||
| Title: | miR-223/FBW7 axis regulates doxorubicin sensitivity through epithelial mesenchymal transition in non-small cell lung cancer. | ||||||||||
| Author: | Li, Renyuan|Wu, Shengjun|Chen, Xin|Xu, Hongfei|Teng, Peng|Li, Weidong | ||||||||||
| PMID: | 27398136 | ||||||||||
| 21. | |||||||||||
| Journal: | Tumour Biol. 2016 Nov;37(11):15325-15332. | ||||||||||
| Title: | MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma. | ||||||||||
| Author: | Sun, Xin-Fang|Sun, Jin-Ping|Hou, Hong-Tao|Li, Ke|Liu, Xin|Ge, Quan-Xing | ||||||||||
| PMID: | 27704356 | ||||||||||
| 22. | |||||||||||
| Journal: | Oncotarget. 2017 May 2;8(18):29771-29784. | ||||||||||
| Title: | Inhibition of the prolyl isomerase Pin1 enhances the ability of sorafenib to induce cell death and inhibit tumor growth in hepatocellular carcinoma. | ||||||||||
| Author: | Zheng, Min|Xu, Huijuan|Liao, Xin-Hua|Chen, Champ Peng|Zhang, Arina Li|Lu, Wenxian|Wang, Long|Yang, Dayun|Wang, Jichuang|Liu, Hekun|Zhou, Xiao Zhen|Lu, Kun Ping | ||||||||||
| PMID: | 28404959 | ||||||||||
| 23. | |||||||||||
| Journal: | J Biol Chem. 2017 Jun 2;292(22):9022-9033. | ||||||||||
| Title: | Cell cycle-dependent degradation of the methyltransferase SETD3 attenuates cell proliferation and liver tumorigenesis. | ||||||||||
| Author: | Cheng, Xiaoqing|Hao, Yuan|Shu, Wenjie|Zhao, Mengjie|Zhao, Chen|Wu, Yuan|Peng, Xiaodan|Yao, Pinfang|Xiao, Daibiao|Qing, Guoliang|Pan, Zhengying|Yin, Lei|Hu, Desheng|Du, Hai-Ning | ||||||||||
| PMID: | 28442573 | ||||||||||
| 24. | |||||||||||
| Journal: | Mol Cancer. 2017 Jul 17;16(1):123. | ||||||||||
| Title: | Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis. | ||||||||||
| Author: | Wang, Yufeng|Liu, Zhikui|Yao, Bowen|Li, Qing|Wang, Liang|Wang, Cong|Dou, Changwei|Xu, Meng|Liu, Qingguang|Tu, Kangsheng | ||||||||||
| PMID: | 28716020 | ||||||||||
| 25. | |||||||||||
| Journal: | Zhonghua Gan Zang Bing Za Zhi. 2017 May 20;25(5):349-353. | ||||||||||
| Title: | [Copy number aberrations of genes related to extrohepatic metastasis-free survival after operation for hepatocellular carcinoma]. | ||||||||||
| Author: | Bao, L L|Zhu, Z Z|Wen, B J|Wan, X X|Ye, Y Q|Chen, L|He, S Q|Cong, W M | ||||||||||
| PMID: | 28763841 | ||||||||||